Digitale Bibliotheek
Sluiten Bladeren door artikelen uit een tijdschrift
 
Zoeken naar met titel:
ABCDEFGHIJKLMNOPQRSTUVWXYZ

     Tijdschrift beschrijving
       Alle jaargangen van het bijbehorende tijdschrift
         Alle afleveringen van het bijbehorende jaargang
                                       Alle artikelen van de bijbehorende aflevering
 
                             128 gevonden resultaten
nr titel auteur tijdschrift jaar jaarg. afl. pagina('s) type
1 Accuracy of intestinal permeability in predicting the development of complications in patients with liver cirrhosis Ponziani, F.R.
 2016
 48 S1 p. e34-e35
nvt p.
 artikel
2 Accuracy of the latest release of a 2D shear wave elastography method for staging liver fibrosis in patients with chronic hepatitis C: Preliminary results Ferraioli, G.
 2016
 48 S1 p. e62-e63
nvt p.
 artikel
3 Adherence to BCLC treatment algorithm and survival predictors in single node HCC in Italy Pozzan, C.
 2016
 48 S1 p. e27-
1 p.
 artikel
4 Adipose tissue insulin resistance is associated with macrophage activation in non-diabetic patients with non-alcoholic fatty liver disease Marietti, M.
 2016
 48 S1 p. e12-
1 p.
 artikel
5 A.I.S.F. 2016: Abstracts evaluation procedure 2016
 48 S1 p. e65-
1 p.
 artikel
6 All oral sofosbuvir-based antiviral therapy in liver transplant recipients affected by moderate-severe hepatitis C recurrence: Predictors of viral response and survival Arese, D.
 2016
 48 S1 p. e33-
1 p.
 artikel
7 Allosteric modulation of mGlu5 receptors by MPEP protects against hepatic cold ischemia and reperfusion injury Berardo, C.
 2016
 48 S1 p. e48-
1 p.
 artikel
8 Analysis of hemodynamic effects of bosentan on portopulmonary hypertension in short-term and medium-term follow-up: Promising predictors of response to therapy? Ottobrelli, A.
 2016
 48 S1 p. e35-
1 p.
 artikel
9 Angiopoietin-like4 is associated with lipid metabolism and severe fibrosis in non-diabetic patients with non-alcoholic fatty liver disease Rosso, C.
 2016
 48 S1 p. e38-
1 p.
 artikel
10 Are cirrhotic patients awaiting liver transplantation protected against vaccine preventable diseases? Tran Minh, M.
 2016
 48 S1 p. e59-
1 p.
 artikel
11 Circulating microparticles and risk of portal vein thrombosis in patients with liver cirrhosis and hepatocellular carcinoma Zanetto, A.
 2016
 48 S1 p. e37-
1 p.
 artikel
12 Circulating microRNA in hepatocellular carcinoma as prognostic biomarkers Pascut, D.
 2016
 48 S1 p. e23-
1 p.
 artikel
13 Clinical and functional changes associated with the sustained virological response after treatment of genotype-1 HCV recurrence in liver transplant recipients: Does sofosbuvir differ from peg-interferon based therapy? Lenci, I.
 2016
 48 S1 p. e55-
1 p.
 artikel
14 Clinical and virological characteristics of HIV and HCV co-infected versus HCV monoinfected patients: A real-life evaluation in the PITER (Piattaforma Italiana per lo studio della Terapia delle Epatiti viRali) cohort Colombatto, P.
 2016
 48 S1 p. e46-e47
nvt p.
 artikel
15 Clinical and virological profile of patients with diagnosed HCV chronic infection in Italy: Data from PITER cohort study 2016
 48 S1 p. e54-
1 p.
 artikel
16 Clinical determinants of fibrosis progression in an Italian prospective cohort of patients with nonalcoholic fatty liver disease Lombardi, R.
 2016
 48 S1 p. e43-e44
nvt p.
 artikel
17 Clinical outcome in hospitalized cirrhotic patients with bacterial infections treated with empirical or antibiogram-guided therapy Caccamo, G.
 2016
 48 S1 p. e44-e45
nvt p.
 artikel
18 Clinical relevance of accurate HCV genotype and subtype assignment by NS3/NS5A/NS5B direct sequencing in the era of new direct acting antiviral agents Aragri, M.
 2016
 48 S1 p. e1-e2
nvt p.
 artikel
19 Coronary microvascular dysfunction in patients with decompensated cirrhosis: Another tool for understanding cirrhotic cardiomyopathy? Ferrarese, A.
 2016
 48 S1 p. e59-
1 p.
 artikel
20 Development and validation of an on-line web calculator for survival after trans-arterial chemo-embolization for hepatocellular carcinoma Cucchetti, A.
 2016
 48 S1 p. e28-
1 p.
 artikel
21 Diagnostic performance of point share wave elastography (pSWE) in comparison with transient elastography performed by Fibroscan® (TE) and non-invasive scores of fibrosis in primary biliary cirrhosis (PBC) Saffioti, F.
 2016
 48 S1 p. e49-
1 p.
 artikel
22 Differential inflammatory phenotypes upon genetic or pharmacologic inactivation of indoleamine dioxygenase in experimental steatohepatitis Vivoli, E.
 2016
 48 S1 p. e44-
1 p.
 artikel
23 Different prevalence of HCV resistance and HCV quantification within blood and liver samples (tumoral and non tumoral tissues) of HCC/transplanted patients Sorbo, M.C.
 2016
 48 S1 p. e56-
1 p.
 artikel
24 Direct acting antivirals for the treatment of elderly patients with HCV advanced disease in the real life practice Conti, F.
 2016
 48 S1 p. e4-
1 p.
 artikel
25 DPPIV/CD26 and SerpinB3 interaction affects metabolism and clinical outcome in hepatocellular carcinoma Ruvoletto, M.
 2016
 48 S1 p. e49-
1 p.
 artikel
26 Early onset of hyperthension and serum electrolite changes as potential predictive factors of activity in advanced HCC treated with sorafeinb: Results from a retrospective analysis of HCC-AVR group Casadei Gardini, A.
 2016
 48 S1 p. e36-
1 p.
 artikel
27 Editorial Board 2016
 48 S1 p. i-
1 p.
 artikel
28 Efficacy and safety of percutaneous laser ablation therapy for treatment of large HCC Camera, S.
 2016
 48 S1 p. e50-
1 p.
 artikel
29 Efficacy and safety of treatment of acute nonmalignant portal vein thrombosis with subcutaneous fondaparinux in patients with cirrhosis and marked thrombocytopenia Tonon, M.
 2016
 48 S1 p. e25-e26
nvt p.
 artikel
30 ENOS polymorphisms and clinical outcome in advanced HCC patients receiving sorafenib: Final results of the ePHAS Study Casadei Gardini, A.
 2016
 48 S1 p. e23-
1 p.
 artikel
31 Erectile dysfunction in patients with liver cirrhosis Maimone, S.
 2016
 48 S1 p. e36-
1 p.
 artikel
32 Etiology of chronic liver disease and HCC biomarkers Ricco, G.
 2016
 48 S1 p. e52-e53
nvt p.
 artikel
33 Evaluation of mild cognitive dysfunction by Montreal Cognitive Assessment test in patients with chronic HCV infection Pacini, D.G.
 2016
 48 S1 p. e60-
1 p.
 artikel
34 Exogenous administration of recombinant SERPINB3 inhibits cell reprogramming Torchio, E.
 2016
 48 S1 p. e29-
1 p.
 artikel
35 Expression of adrenomedullin in chronic inflammatory liver diseases Sarcognato, S.
 2016
 48 S1 p. e33-
1 p.
 artikel
36 Extrahepatic autoimmunity in patients with autoimmune hepatitis (AIH) Cazzagon, N.
 2016
 48 S1 p. e53-
1 p.
 artikel
37 Feasibility and efficacy of sofosbuvir-based antiviral therapy before liver transplantation to prevent HCV recurrence: A monocentric experience Strona, S.
 2016
 48 S1 p. e29-
1 p.
 artikel
38 FNDC5 rs3480 A>G polymorphism disentangles steatosis from fibrosis severity in patients with nonalcoholic fatty liver disease Petta, S.
 2016
 48 S1 p. e10-
1 p.
 artikel
39 Functionalized polymers to target SerpinB3 in hepatoma cells Quarta, S.
 2016
 48 S1 p. e45-
1 p.
 artikel
40 Further increase in biliary excretion of asymmetric dimethylarginine during hepatic ischemia/reperfusion injury by obeticholic acid, a farnesoid-X-receptor agonist Di Pasqua, L.G.
 2016
 48 S1 p. e55-
1 p.
 artikel
41 HBsAg mutations correlated with HCC in vivo affect HBsAg release and favor cell proliferation in vitro Salpini, R.
 2016
 48 S1 p. e20-
1 p.
 artikel
42 HBV-HDV co-infection constrains HBV genetic evolution in HBsAg Colagrossi, L.
 2016
 48 S1 p. e47-e48
nvt p.
 artikel
43 HCV-related mixed cryoglobulinemia: Data from PITER, a nationwide Italian HCV cohort study Weimer, L.E.
 2016
 48 S1 p. e6-e7
nvt p.
 artikel
44 Hepatitis B core-related antigen levels during nucleos(t)ide analogues or pegylated-interferon treatment in patients chronically infected with HBV genotype-D Caviglia, G.P.
 2016
 48 S1 p. e63-e64
nvt p.
 artikel
45 Hepatitis C core antigen assay for the monitoring of treatment with direct antiviral agents in patients with chronic Hepatitis C Loggi, E.
 2016
 48 S1 p. e61-
1 p.
 artikel
46 Hepatocellular carcinoma developing in European patients with prolonged HBV suppression: Biological and clinical features, and outcome Lampertico, P.
 2016
 48 S1 p. e48-e49
nvt p.
 artikel
47 Higher simeprevir plasma exposure when co-administered with sofosbuvir leads to higher risk of dermatological toxicity De Nicolò, A.
 2016
 48 S1 p. e58-
1 p.
 artikel
48 High Mobility Group Box 1 (HMGB1) and neutrophils an unexpected role in non-alcoholic fatty liver disease: Inhibition of T cell activation and proliferation Antonucci, L.
 2016
 48 S1 p. e11-
1 p.
 artikel
49 High-powered microwaves (MWS) ablation of intermediate Hepatocellular Carcinoma (HCC) in cirrhosis: A multicenter, prospective study Giorgio, A.
 2016
 48 S1 p. e57-
1 p.
 artikel
50 High SVR rates with SMV+SOF in HCV GT1 and GT4 patients with cirrhosis or advanced fibrosis: A real practice analysis from a large regional database in Tuscany, Italy Salomoni, E.
 2016
 48 S1 p. e5-
1 p.
 artikel
51 Hippocampal axis dysfunction evaluation by Rey-Osterrieth Complex figure test (RCFT) should be included in minimal hepatic encephalopathy (MHE) assessment Casu, S.
 2016
 48 S1 p. e62-
1 p.
 artikel
52 Hypoxia-inducible factor-2α affects fibrogenic progression of experimental non-alcoholic fatty liver disease Morello, E.
 2016
 48 S1 p. e10-
1 p.
 artikel
53 Immunosuppression-driven HBV reactivation in patients with resolved HBV infection correlates with a relevant risk of death and with evolution towards active chronical infection Battisti, A.
 2016
 48 S1 p. e18-e19
nvt p.
 artikel
54 Impact and mechanisms of insulin resistance on liver damage progression in a mouse model of non-alcoholic steatohepatitis (NASH) Meroni, M.
 2016
 48 S1 p. e11-
1 p.
 artikel
55 Impact of DAA therapy on health-related quality of life in liver transplanted patients. Is there a role for ribavirin? Lionetti, R.
 2016
 48 S1 p. e58-
1 p.
 artikel
56 Impact of different Sofosbuvir-based direct acting antiviral (DAA) regimen in elderly cirrhotic patients: A real world experience from CLEO Group Pellicelli, A.M.
 2016
 48 S1 p. e42-
1 p.
 artikel
57 Incidence, predictors and outcomes of acute on chronic liver failure in outpatients with cirrhosis Piano, S.
 2016
 48 S1 p. e24-
1 p.
 artikel
58 Increased plasma levels of Von Willebrand factor (VWF) and Factor VIII (FVIII) during acute bacterial infection drive a pro-hemostatic imbalance and herald severe outcome in cirrhosis La Mura, V.
 2016
 48 S1 p. e13-
1 p.
 artikel
59 Influence of donor and recipient gender on liver transplantation outcomes in Europe: A ELTR study Germani, G.
 2016
 48 S1 p. e7-
1 p.
 artikel
60 In hepatocellular carcinoma miR-494 up-regulates the AKT/mTOR pathway and is involved in Sorafenib resistance Pollutri, D.
 2016
 48 S1 p. e28-
1 p.
 artikel
61 Involvement of copper in the liver tumorigenesis Porcu, C.
 2016
 48 S1 p. e32-
1 p.
 artikel
62 ITPA deficiency does not predict anaemia during Ribavirin containing DAA all oral regimens for HCV De Nicola, S.
 2016
 48 S1 p. e50-
1 p.
 artikel
63 Kidney involvement in HCV child-A cirrhosis Palazzo, D.
 2016
 48 S1 p. e4-e5
nvt p.
 artikel
64 Lack of NLRP3-inflammasome leads to gut-liver axis derangement and increases hepatic injury in a mouse model of NAFLD Pierantonelli, I.
 2016
 48 S1 p. e9-e10
nvt p.
 artikel
65 Laparoscopic ablation and salvage transplantation for patients with hepatocellular carcinoma Cillo, U.
 2016
 48 S1 p. e24-
1 p.
 artikel
66 Laparoscopic thermal ablation of hepatocellular carcinoma unsuitable for percutaneous treatments or hepatic resection: A comparative study Barabino, M.
 2016
 48 S1 p. e47-
1 p.
 artikel
67 Lean-non alcoholic fatty liver disease (NAFLD) with central visceral obesity identifies patients with more severe disease Lombardi, R.
 2016
 48 S1 p. e43-
1 p.
 artikel
68 Liver and adipose tissue interplay through the up-regulation of the Th17 pathway Chackelevicius, C.M.
 2016
 48 S1 p. e39-
1 p.
 artikel
69 Liver transplantation in HIV-positive patients: The initial experience Di Benedetto, C.
 2016
 48 S1 p. e62-
1 p.
 artikel
70 Long term outcome of splanchnic vein thrombosis (SVT) in cirrhosis Senzolo, M.
 2016
 48 S1 p. e17-
1 p.
 artikel
71 Low-dose ribavirin seems to have no impact on response to DAA-regimens for HCV therapy in advanced liver disease Valente, G.
 2016
 48 S1 p. e43-
1 p.
 artikel
72 Low Molecular Weight Heparin (LMWH) treatment does not increase the risk of bleeding after prophylactic endoscopic variceal band ligation in patients with cirrhosis Bianchini, M.
 2016
 48 S1 p. e21-
1 p.
 artikel
73 Lysosomal acid lipase activity is reduced in patients with cirrhosis and associated with surrogate indices of portal hypertension Vespasiani Gentilucci, U.
 2016
 48 S1 p. e34-
1 p.
 artikel
74 Management of malnutrition in patients with cirrhosis requires a personalized educational approach Giannone, F.A.
 2016
 48 S1 p. e16-e17
nvt p.
 artikel
75 MBOAT7 locus rs641738 variant predisposes to hepatocellular carcinoma in nonalcoholic fatty liver Donati, B.
 2016
 48 S1 p. e7-e8
nvt p.
 artikel
76 MELD score predicts outcome of patients with advanceed hepatocellular carcinoma treated with sorafenib Casadei Gardini, A.
 2016
 48 S1 p. e52-
1 p.
 artikel
77 MiR-B-index: A candidate bio-marker to identify the immune control of HBV infection in chronic hepatitis B patients treated with nucleos(t)ide-analogues Cavallone, D.
 2016
 48 S1 p. e1-
1 p.
 artikel
78 Monitoring liver steatosis by means of a new ultrasound imaging system (Steatometer) in HCV treated patients Faita, F.
 2016
 48 S1 p. e50-e51
nvt p.
 artikel
79 Multimodality treatment of hepatocellular carcinoma: How field practice complies with international recommendations Triolo, M.
 2016
 48 S1 p. e26-
1 p.
 artikel
80 Nlrp3 inflammasome activation by microbial products leads to Il-18 synthesis and impaired epithelial barrier function in cholangiocytes Maroni, L.
 2016
 48 S1 p. e12-
1 p.
 artikel
81 NS3 genetic variability in HCV genotype 1a isolates from liver tissues and serum samples of treatment-naïve patients with chronic hepatitis C D’Aliberti, D.
 2016
 48 S1 p. e35-e36
nvt p.
 artikel
82 Percutaneous electrochemotherapy of malignant main portal veins thrombosis: A prospective case series Tarantino, L.
 2016
 48 S1 p. e40-
1 p.
 artikel
83 Peripheral NK cells in patients with HCV recurrence after liver transplantation during interferon-free antiviral therapy Zanetto, A.
 2016
 48 S1 p. e46-
1 p.
 artikel
84 PIVKA-II is a useful tool for the diagnosis of early hepatocellular carcinoma Saitta, C.
 2016
 48 S1 p. e30-
1 p.
 artikel
85 Plasma ribavirin concentration in HCV cirrhotic patients treated with Direct Antiviral Agents (DAAs) Biliotti, E.
 2016
 48 S1 p. e51-
1 p.
 artikel
86 Prediction of post-operative liver failure in cirrhotic patients undergoing surgical resection for hepatocellular carcinoma: The role of liver stiffness measured by acoustic radiation force impulse and the proposal for a new mathematical model score Iegri, C.
 2016
 48 S1 p. e40-e41
nvt p.
 artikel
87 Pre-emptive post-transplant HCV treatment with IFN-free DAA: Preliminary results from a pilot study Pasulo, L.
 2016
 48 S1 p. e60-
1 p.
 artikel
88 Presence of resistance associated variants in patients with virological failure to new direct acting antivirals and requirement of unconventional regimens for re-treatment Di Maio, V.C.
 2016
 48 S1 p. e3-e4
nvt p.
 artikel
89 Presentation and outcome in patients with drug induced liver injury: A three-year experience Bergamo, C.
 2016
 48 S1 p. e53-
1 p.
 artikel
90 Prevalence and features of chronic viral hepatitis and HIV/viral hepatitis coinfections in Italian prisons Stasi, C.
 2016
 48 S1 p. e38-
1 p.
 artikel
91 Prevalence and risk factors for hepatitis C virus infection in a metropolitan area of Italy Morisco, F.
 2016
 48 S1 p. e31-
1 p.
 artikel
92 Primary biliary cholangitis in elderly patients Franceschet, I.
 2016
 48 S1 p. e53-e54
nvt p.
 artikel
93 Prognostic relevance of stage migration in patients with hepatocellular carcinoma: A multicenter cohort study Vitale, A.
 2016
 48 S1 p. e9-
1 p.
 artikel
94 Progressive alterations of cardiopulmonary hemodynamics accompanied by increasing levels of C reactive protein (CRP) occur in patients in different stages of cirrhosis and predict death in decompensated cirrhosis Turco, L.
 2016
 48 S1 p. e15-e16
nvt p.
 artikel
95 Proof of multiple mechanisms of solute-free water retention in experimental ascitic cirrhosis Sansoè, G.
 2016
 48 S1 p. e25-
1 p.
 artikel
96 P66shc and SerpinB3 interplay affects HCC clinical outcome and cell fate Ruvoletto, M.
 2016
 48 S1 p. e30-
1 p.
 artikel
97 Renalase, a new protagonist of abnormal adrenergic activation in liver cirrhosis? Sansoè, G.
 2016
 48 S1 p. e25-
1 p.
 artikel
98 Risk factors of an early emergent hospital readmission due to a re-infection in patients with cirrhosis after a recovery from a bacterial or fungal infection Morando, F.
 2016
 48 S1 p. e19-
1 p.
 artikel
99 Role of AKI in patients with decompensated cirrhosis: Preliminary results from a prospective study in two Italian University Hospitals La Mura, V.
 2016
 48 S1 p. e21-
1 p.
 artikel
100 Role of the protein kinase CK2 in the biology of cholangiocarcinoma cells Di Maira, G.
 2016
 48 S1 p. e20-
1 p.
 artikel
101 Ruvbl1 regulates liver glucose metabolism via the Akt/mTOR pathway: Implications for hepatocellular carcinoma progression Mello, T.
 2016
 48 S1 p. e8-e9
nvt p.
 artikel
102 Safety and efficacy of sofosbuvir-based antiviral therapy immediately after liver transplantation: A matched case–control analysis Sacco, M.
 2016
 48 S1 p. e32-
1 p.
 artikel
103 Screening and surveillance of esophageal varices: Validation of Baveno VI criteria in a cohort of cirrhotic HCV patients Tosetti, G.
 2016
 48 S1 p. e17-
1 p.
 artikel
104 SerpinB3 up-regulates hypoxia inducible factors-1α and -2α in liver cancer cells through different mechanisms Cannito, S.
 2016
 48 S1 p. e19-
1 p.
 artikel
105 Silencing of the focal adhesion kinase reduces hepatocellular carcinoma growth affecting enhancer of zeste homolog 2 transcription and activity Gnani, D.
 2016
 48 S1 p. e14-
1 p.
 artikel
106 Sorafenib in clinical practice: Pooled analysis of two prospective observational studies in hepatocellular carcinoma (HCC) Di Costanzo, G.G.
 2016
 48 S1 p. e45-e46
nvt p.
 artikel
107 Striking gender differences in emotional intelligence among HCV cirrhotic patients Taliani, G.
 2016
 48 S1 p. e57-
1 p.
 artikel
108 Survival in patients with hepatocellular carcinoma and portal vein thrombosis Pisano, G.
 2016
 48 S1 p. e63-
1 p.
 artikel
109 Telomerase extratelomeric effects in hepatocellular carcinoma: Molecular targeting to impair tumoral networks in HCC Martinozzi, I.
 2016
 48 S1 p. e22-
1 p.
 artikel
110 Terlipressin given by continuous intravenous infusion vs terlipressin given by intravenous boluses in the treatment of hepatorenal syndrome in patients with cirrhosis: Final results of a controlled clinical study Cavallin, M.
 2016
 48 S1 p. e15-
1 p.
 artikel
111 The balance between fibrosis and regeneration in chronic liver injury: The role of gender Crescenzi, M.
 2016
 48 S1 p. e26-
1 p.
 artikel
112 The combination of IFN-lambda-4 and HLA-DPB1 polymorphisms accurately predict HBsAg loss in IFN treated genotype D HBeAg-negative patients with chronic hepatitis B Lampertico, P.
 2016
 48 S1 p. e3-
1 p.
 artikel
113 The CXCL12/CXCR7 system mediates migration and survival of cholangiocarcinoma (CCA) cells through interaction with CXCR4 and β-arrestin-2 Gentilini, A.
 2016
 48 S1 p. e13-
1 p.
 artikel
114 The gut microbiota of cirrhotic patients with poor nutritional status: Preliminary evidences Ponziani, F.R.
 2016
 48 S1 p. e30-e31
nvt p.
 artikel
115 The intra-tumor heterogeneity of C19MC miRNA cluster expression mirrors the presence of the side population in HCC Colombo, F.
 2016
 48 S1 p. e14-
1 p.
 artikel
116 The protease-inhibitor SerpinB3 modulate survival and Wnt pathway of inflammatory human monocytes Cappon, A.
 2016
 48 S1 p. e27-
1 p.
 artikel
117 The role of mir-124 and aurora kinase A in the multidrug resistance in HCC Popović, P.
 2016
 48 S1 p. e8-
1 p.
 artikel
118 The role of serum alphafetoprotein determination in HCV-cirrhosis after antiviral treatment Della Corte, C.
 2016
 48 S1 p. e54-
1 p.
 artikel
119 The TLR10 polymorphism rs4129009 is associated to poor 28-day survival in patients with cirrhosis and acute on chronic liver failure precipitated by bacterial infection Domenicali, M.
 2016
 48 S1 p. e16-
1 p.
 artikel
120 Transition of pediatric liver transplanted recipients to Adult Healthcare Service: A single center cohort Ferrarese, A.
 2016
 48 S1 p. e61-
1 p.
 artikel
121 Treatment failure to first-line direct antiviral (DAA) in HCV-related advanced liver disease: An Italian real-life urban setting Di Paolo, D.
 2016
 48 S1 p. e2-e3
nvt p.
 artikel
122 Treatment of elderly HCV patients with severe fibrosis: safety and efficacy data from RESIST-HCV, a large regional database Di Marco, V.
 2016
 48 S1 p. e37-
1 p.
 artikel
123 Treatment of healthcare associated urinary tract infections: May an empirical broad spectrum antibiotic therapy improve survival? An analysis by a randomized trial Lucidi, C.
 2016
 48 S1 p. e31-
1 p.
 artikel
124 Treatment of high baseline viral load chronic hepatitis B using sequential therapy with entecavir and PEG-IFN Boglione, L.
 2016
 48 S1 p. e56-
1 p.
 artikel
125 Treatment with direct acting antiviral agents-based regimen in HCV patients with advanced liver disease: Analysis of an Italian multicenter observational study Conti, F.
 2016
 48 S1 p. e51-e52
nvt p.
 artikel
126 Unexpected very early atherosclerotic and cardiac damage in patients undergoing liver transplantation Pisano, G.
 2016
 48 S1 p. e39-
1 p.
 artikel
127 Vaccine-escape HBsAg mutants circulating among genotype D HBV-infected patients correlate with atypical serological profiles, high viremia and transaminases: Potential impact on vaccination strategies Salpini, R.
 2016
 48 S1 p. e5-e6
nvt p.
 artikel
128 Validation of a method for establishing allocation equity among patients with and without hepatocellular carcinoma on a common waiting list Vitale, A.
 2016
 48 S1 p. e22-
1 p.
 artikel
                             128 gevonden resultaten
 
 Koninklijke Bibliotheek - Nationale Bibliotheek van Nederland